Temozolomide in paediatric high-grade glioma: a key for combination therapy? - Wikidata - awgldk - TriplyDB

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

http://www.wikidata.org/entity/Q33361765

about

Temozolomide for children and adolescents with diffuse intrinsic pontine glioma Temozolomide: a milestone in neuro-oncology and beyond?Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors.Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.Extent of surgical resection and adjuvant temozolomide improves survival in pediatric GBM: a single center experience.Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.MGMT gene promoter methylation in pediatric glioblastomas.Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective, multicenter study.

P2860

Q24200164-95CC6D6C-8447-4C9E-9580-39D54969DC84 Q33372340-292EA401-2D56-40A2-AA90-AEAF8BA3950F Q33391731-434270DE-FB33-40BD-9FE3-E23A90D94592 Q33407691-03402AF8-A177-4913-8B47-0F3F33C0BBC3 Q33409117-5847E257-5EF9-4FAF-A2F2-D5669F16A668 Q34571940-B12AE391-9157-4E0B-91AC-08CEAE2E009A Q35769714-87AF2134-6914-428E-B7C5-6D98F9EFAF98 Q37422646-B7D08B0A-D2CA-4F4E-80D8-4E82C5A519EB Q37564835-7D1A84E6-E31B-4C07-960D-519A28C9607C Q38086448-715360A1-BC22-44FB-902F-8200B5A99D11 Q38829504-86CFEDC2-9E05-4F62-B628-E84B9E66E62C Q41003114-6ABF00FA-E8A6-427D-8960-1BC58314CA3B Q43002702-7A2CB6BC-2A8B-471B-92C3-795805D5F4B1 Q44596535-8D696350-66CB-40A8-A835-5BABF849A636 Q46469386-BB4B5072-C3E3-4D59-88B4-BBCFAA8D5C84 Q48519428-3B30BEC1-7840-4996-964A-EDE0CA8943C4

P2860

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

http://www.wikidata.org/entity/Q33361765

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

@ast

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

@en

type

label

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

@ast

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

@en

prefLabel

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

@ast

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

@en

P1433

Q33361765-74E78C63-8DE0-412E-BF81-FC8B12C4C893

P1476

Q33361765-AD27139F-AC65-48D0-923D-050737F0EA7A

P2093

Q33361765-3D16D303-C923-4699-806D-0206E5100D08

Q33361765-5FC2F1E3-D0E7-46C5-AA30-F7F1CDCE01BD

Q33361765-6E9DFDCA-1935-4CB0-AED9-F54EA274CCBE

Q33361765-A594797B-328A-4874-9E0A-0C20F2979D33

Q33361765-BFBB0044-DFF7-4D45-8D56-F085933AD166

Q33361765-F59DBE73-6998-4D2C-8906-C10265213E6B

P2860

Q33361765-0D5EEDD7-585F-4F3C-89EC-BD9BB303209B

Q33361765-1A2C2F21-D0CB-4B5C-A937-F6CB9F432E4D

Q33361765-1BB95956-CB18-4ECD-A6DD-EFA07D60F3C5

Q33361765-21265661-AE31-41C7-AC46-CF55F443AEC1

Q33361765-22D4DC31-FECB-4C66-A02A-2531DD0AE41E

Q33361765-3C3EA36D-C4CE-4E4F-92A8-2D6B63055CDA

Q33361765-3CB30EA5-226A-4F26-9943-FBFF811213E9

Q33361765-4EBD919A-5C2D-40D6-B428-EAA8C1368282

Q33361765-55A69769-623B-48A0-83B6-4E243E91868A

Q33361765-571D90B1-9540-4AE4-8E8F-9C2E6F00E1F8

P2888

Q33361765-8F5017AB-9D91-4124-AB5D-C74B75EFB12E

P304

Q33361765-B20C4406-966E-46DB-B3BC-D58690769071

P31

Q33361765-B075E000-7877-48FC-A7E1-F6523351871F

P356

Q33361765-BE758EE7-16FA-4321-900F-109155045EBB

P407

Q33361765-89C1EC00-91D7-4291-9ADF-454BF7BAEFC1

P433

Q33361765-85F4B0A5-B6B8-4B52-ACC4-5C5176C4802F

P478

Q33361765-BD612CBE-9AF0-47E2-9D0F-8E30ECF77A01

P577

Q33361765-0A82BA53-64A8-42A8-B499-941B61798C00

P5875

Q33361765-ABDCBC46-26ED-4A27-8D01-44135AD63B58

P6179

Q33361765-2AC86F12-D0A6-4D7E-8B58-23D0A7FAEEC1

P698

Q33361765-A9CA4057-80C4-4E4E-A7B5-E10471237BA0

P932

Q33361765-771FAF32-9179-42FE-BC08-08BBFA929D2A

P356

P1433

British Journal of Cancer

P1476

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

@en

P2093

A C Verschuur

http://www.w3.org/2001/XMLSchema#string

A Lelouch-Tubiana

http://www.w3.org/2001/XMLSchema#string

C Kalifa

http://www.w3.org/2001/XMLSchema#string

D Couanet

http://www.w3.org/2001/XMLSchema#string

G Vassal

http://www.w3.org/2001/XMLSchema#string

J Grill

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of temozolomide (CCRG 81045: M&B; 39831: NSC 362856)

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas

Trends in incidence of primary brain tumors in the United States, 1985-1994.

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

P2888

P304

425-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601997

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8443927

http://www.w3.org/2001/XMLSchema#string

P6179

1016509565

http://www.w3.org/2001/XMLSchema#string

P698

15266331

http://www.w3.org/2001/XMLSchema#string

P932

2409857

http://www.w3.org/2001/XMLSchema#string